YLYeon J. Lee

Yeon J. Lee

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yeon J. Lee has a total of 11 co-authors. Here are the top co-authors by number of shared publications:

  • Andrew Dillin

    Molecular and Cell Biology, University of California, Berkeley, Berkeley, California 94720, USA

    1 shared publication
  • Dirk Hockemeyer

    Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, USA

    1 shared publication
  • Donald C. Rio

    Molecular and Cell Biology, University of California, Berkeley, Berkeley, California 94720, USA

    1 shared publication
  • Donald C. Rio

    Aligning Science Across Parkinson’s (ASAP) Collaborative Research Network, Chevy Chase, USA

    1 shared publication
  • Frank Soldner

    Dominick P. Purpura Department of Neuroscience, Albert Einstein College of Medicine, Rose F. Kennedy Center, Albert Einstein College of Medicine

    1 shared publication
  • Hanqin Li

    Aligning Science Across Parkinsonʼs ASAP Collaborative Research Network University of California 94720 2081 Berkeley Berkeley Chevy Chase CA MD USA

    1 shared publication

Latest Publications

  • The hnRNPA1 D262V amyotrophic lateral sclerosis (ALS) mutation is linked to mitochondrial dysfunction

    by Yeon J. Lee, Koning Shen, Andrew Dillin, Donald C. Rio

    Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder marked by motor neuron loss and has been genetically linked to mutations in RNA-binding proteins. A mutation D262V in the RNA-binding protein hnRNPA1, found in a subset of ALS patients, causes widespread splicing pattern changes. Cells expressing this hnRNPA1 mutation exhibit aggregation, reduced proliferation, altered stress granules and abnormal neuronal growth. To further elucidate how a single amino acid substitution in a splicing factor might impact cell growth, we employed ribosome profiling to study translational dynamics across the transcriptome in hnRNPA1 mutant cells. Differential ribosome occupancy was observed for a small number of transcripts linked to synaptic organization and GTPase functions, as well as disrupted codon usage and a global stalling of translation. This downregulation of translation coincided with suppression of the mTOR/AKT signaling pathway. RNA splicing changes in transcripts from genes linked to cilia/cell projections, GTPase cycles and glutamate signaling were also observed. Importantly, major mitochondrial dysfunction and mitochondrial fragmentation were found in hnRNPA1 D262V mutant cells. Overall, this study demonstrates how a single amino acid change in an RNA binding protein can contribute to disrupting cell growth and mitochondrial function related to defects linked to neuronal death in ALS.

  • Open Access

    Alternative pre-mRNA Splicing and Gene Expression Patterns in Midbrain Lineage Cells Carrying Familial Parkinson’s Disease Mutations

    by Yeon J. Lee, Khaja Syed, Oriol Busquets, Hanqin Li, Jesse Dunnack, Helen S. Bateup, Frank Soldner, Dirk Hockemeyer, Donald C. Rio

    Parkinson’s disease (PD) arises from genetic and environmental factors. Human genetics has identified mutations in ∼20 inherited familial genes linked to monogenic forms of PD. To investigate the effects of individual familial PD mutations, human pluripotent embryonic stem cells (hPSCs) carrying 12 distinct familial PD mutations were differentiated into midbrain lineage cells, including dopaminergic (mDA) neurons. Global gene expression and pre-mRNA splicing patterns were analyzed in midbrain cultures carrying pathogenic PD mutations in the PRKN , SNCA , LRRK2 , PINK1 , DNAJC6 , FBXO7 , SYNJ1 , DJ1, VPS13C , ATP13A2 and GBA1 genes. We have grouped the analysis of these familial PD mutations to genes expressed in mDA neurons and whose pre-mRNA splicing changes are linked to known PD defects in transport, cytoskeleton, lysosomes and mitochondria. Importantly, we have also shown that subsets of these splicing changes overlap with changes found in PD patient postmortem brains. Mutation-specific pre-mRNA isoforms may function as both diagnostic biomarkers for familial PD-associated genotypes and promising therapeutic targets.